These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Prevention of graft-versus-host disease using antibody to Thy 1. A role for complement in vivo.
    Author: Hamilton BL, Harris D.
    Journal: Transplantation; 1985 Jul; 40(1):90-6. PubMed ID: 2861676.
    Abstract:
    An in vitro assay was used to determine whether mouse complement (C') was able to lyse T cells coated with a monoclonal IgM anti-Thy-1 antibody. Using lymph node cells (LNC) as targets, it was found that antibody-coated mature T cells were efficiently lysed by serum from C57BL/6, but inefficiently lysed by serum from BALB/c mice. Serum from both strains lysed antibody-coated thymocytes, demonstrating that BALB/c serum is not deficient in one of the C' components. The lytic activity of BALB/c serum could be improved by increasing the concentration of monoclonal anti-Thy-1 used to coat the target LNC. In contrast, serum from C5-deficient A/HeJ mice was unable to lyse either of the antibody-coated target cells in vitro. These in vitro results were confirmed in vivo using a model of lethal graft-versus-host disease (GVHD) induced to minor histocompatibility antigens. In this model, GVHD occurs when lethally irradiated mice are transplanted with bone marrow plus spleen cells from H-2-identical donor mice. GVHD is prevented when T cells are removed from the cells by in vitro treatment with anti-Thy-1 antibody plus rabbit C'. As predicted by the in vitro data, C57BL/6 mice were protected from GVHD when transplanted with LP cells treated with a 1:100 dilution of anti-Thy-1 antibody, but without complement, but BALB/c recipients of antibody-coated B10.D2/nSN cells were not. When the concentration of anti-Thy-1 used to coat the donor cells was increased to 1:50, 8 of 9 recipients were protected from GVHD. In contrast, none of the C5-deficient DBA/2 recipients of anti-Thy-1 (1:50 dilution) treated B10.D2 cells were protected from GVHD. Complement-mediated lysis appears to be the primary mechanism by which T cells coated with a monoclonal IgM anti-Thy-1 antibody are functionally inactivated in vivo.
    [Abstract] [Full Text] [Related] [New Search]